OTC/SmallCap IRW

Sasol commits to net zero ambition by 2050, triples 2030 GHG emission reduction targets

JOHANNESBURG, Sept. 22, 2021 /PRNewswire/ -- Sasol Limited (Sasol) today announced its updated strategy that commits it to be at net zero emissions by 2050. This is in line with Sasol's commitment to accelerate its transition to a low carbon world in support of the objectives of the Paris Agreeme...

2021-09-22 22:07 8551

Arçelik joins the UN Global Compact CFO Taskforce to align finance and sustainability for real world change

ISTANBUL, Sept. 22, 2021 /PRNewswire/ -- Arçelik A.Ş. (IST: ARCLK) ("Arçelik"), the global leading consumer durables and electronics manufacturer, has announced that Polat Şen, the Chief Financial Officer (CFO) of Arçelik has joined the UN Global Compact CFO Taskforce. With 60 members across 23 ...

2021-09-22 18:48 6706

Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug

SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today on the significant advantages gained by remdesivir encapsulation ...

2021-09-22 18:45 5972

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

* Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety Disorder * Phase 2 clinical trial on target to start by end of 2021 and expected to read out topline data by end of 2022 ADELAIDE, Australia, Sept....

2021-09-20 18:00 4167

BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone

VANCOUVER, British Columbia, Sept. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that cancer vaccine manufacturing partner Bio Elpida inLyon, France, has reached major milestones in the development of the bioproduction proce...

2021-09-17 15:00 5862

Luxventure Entered into Agreement with Tianjin China Travel Cultural Development Company, a subsidiary of China Travel Services

SHISHI, China, Sept. 16, 2021 /PRNewswire/ -- KBS Fashion Group Limited ("KBS" or the "Company") (NASDAQ: KBSF), a leading fully-integrated casual menswear company in China and through the brand of Luxventure, engaging in cross-border merchandise, airfare and tourism business, announced today t...

2021-09-16 21:36 8274

Sasol, Haldor Topsøe expand G2LTM licensing collaboration to grow sustainable synthetic fuels and chemicals globally

JOHANNESBURG, Sept. 15, 2021 /PRNewswire/ -- Haldor Topsøe and Sasol have expanded collaboration to jointly license and develop their technologies for sustainable liquid fuels and chemicals production through Fischer-Tropsch (FT) technology. Sasol and Topsøe currently offer integrated end-to-end...

2021-09-15 20:23 7842

WeTrade to Attend 2021 World Internet Conference

BEIJING, Sept. 15, 2021 /PRNewswire/ -- WeTrade Group Inc. ("Wetrade" or the "Company") (US: WETG), a leading technical service provider of SAAS and Cloud Intelligent System for micro businesses, today announced that it will attend the 2021 World Internet Conference ("WIC") as the service provide...

2021-09-15 19:00 7886

10,000 green hydrogen generators per month: groundbreaking for Enapter electrolyser mass production in North Rhine-Westphalia

Acting, not talking. -  Enapter Campus enables mass production of AEM Electrolysers and serves as a blueprint for further Enapter production facilities worldwide -  Electrolyser production, warehouse storage and offices, as well as research and development laboratories will be built over 82,000...

2021-09-15 04:25 5151

BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs

VANCOUVER, BC, Sept. 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320, the company's COVID-19 vaccine candida...

2021-09-14 15:00 5957

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...

2021-09-13 19:00 6484

ChipMOS REPORTS RECORD AUGUST 2021 REVENUE; 26.1% GROWTH YEAR OVER YEAR

HSINCHU, Sept. 10, 2021 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"...

2021-09-10 18:00 17540

Ossen Innovation Announces Completion of Merger

SHANGHAI, Sept. 9, 2021 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced the completion of the merger contemplated by th...

2021-09-10 10:00 18921

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Partnership will bring first GMP manufactured products to be sold through Valens in bothAustralia and New Zealand Access to Epsilon's GMP facility in Australia to provide Valens with future access to global markets includingLatin America, Europe, UK and Asia-Pacific KELOWNA, BC, Sept. 8, 2021 ...

2021-09-08 19:00 4050

Luxventure Entered into Agreement with Hainan Supply and Marketing Daji Digital Technology Industry Co., Ltd., the cross-border E-commerce subsidiary of Hainan Airline

SHISHI, China, Sept. 7, 2021 /PRNewswire/ -- KBS Fashion Group Limited ("KBS" or the "Company") (NASDAQ: KBSF

2021-09-08 03:39 9391

IINX's subsidiary applied for a patent on high rate rapid charge-discharge aluminum ion battery to China Intellectual Property Administration and has been accepted

LAS VEGAS, Sept. 7, 2021 /PRNewswire/ -- Ionix Technology, Inc. (OTCQB: IINX), ("Ionix Technology", "IINX" or "the Company"), today announced that one of Ionix's wholly-owned subsidiaries, Huixiang Energy Technology (Suzhou) Co., Ltd (Huixiang Energy), has submitted a patent application for its s...

2021-09-07 21:15 7170

Sasol and Central Energy Fund sign strategic MOU to accelerate gas development in South Africa

JOHANNESBURG, Sept. 7, 2021 /PRNewswire/ -- Sasol and the Central Energy Fund (CEF) have signed a memorandum of understanding (MOU) to collaborate on accelerating the development of gas solutions inSouth Africa. This agreement brings togetherSouth Africa's two leading pioneers of the gas industry...

2021-09-07 20:58 6358

Recon Announces RMB9 Million Contract for Disposal of Oil Sludge from Yumen Oilfield

BEIJING, Sept. 7, 2021 /PRNewswire/ -- Recon Technology Limited (NASDAQ: RCON) ("Recon" or the "Company") today announced that its subsidiary, Gansu BHD Environmental Technology Co., Ltd ("Gansu BHD"), and Yumen Oilfield Engineering Construction Co., a wholly-owned subsidiary of China National Pe...

2021-09-07 20:30 6024

Tantech Subsidiary Completes Another Major New Order for 50 Midibuses

LISHUI, China, Sept. 7, 2021 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), a clean energy company inChina, today announced that its subsidiary, Shangchi Automobile Co., Ltd., has fulfilled another major new order for 50 midibuses, with delivery for use inEgypt....

2021-09-07 20:00 7144

Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration

VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Sept. 7, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce that the Scientific Advisor for its CoviDTH program,Yvelise Barrios, MD, PhD, and Clinical Immuno...

2021-09-07 20:00 6587
1 ... 70717273747576 ... 89

Week's Top Stories